<p>Nemysis Limited is pleased to announce the successful acquisition of TFarma SRL ("TFarma") by its wholly-owned subsidiary, Enteralia Bioscience SRL ("Enteralia").</p>

Nemysis is pleased to announce the further strengthening of its IP portfolio in relation to its unique and innovative nanoparticulate oral iron supplement, IHAT (Iron Hydroxide Adipate Tartrate), for the safe treatment of iron deficiency and iron deficiency anaemia.

Nemysis Limited announces the issuance of a Canadian Patent for E40, a novel endoprotease for treatment and management of Celiac Disease and Gluten Intolerance.

Nemysis Ltd Announces Grant of First Chinese Patent for IHAT, the Novel Iron Nanoparticulate Supplement for Iron Deficiency (ID) and Iron Deficiency With Anemia (IDA).

Nemysis Ltd announced today the appointment of Dr. Margit Holzer to its Scientific Advisory Board (SAB).

Nemysis Ltd today announces the appointment of internationally recognized drug discovery and development expert Linda Cavaletti to its Scientific Advisory Board (SAB).

Nemysis Limited today announced that it appointed Estrella Bengio as Global Regulatory Affairs Head.

Nemysis Limited, the Dublin-based pharmaceutical and healthcare Company focused on iron deficiency/anemia and gluten sensitivity has announced that it has completed a €2.65M capital raise.

Sukarya and the Maternal & Child Health Program at The George Washington University signed a letter of intent to collaborate on future initiatives focused on new and innovative intervention research to improve maternal and child health outcomes while working towards improving the health of women, adolescents and children in India.

The Public Health and Nutrition conference is going to be a forum for academicians, nutritionists, healthcare providers, dietitians, public health specialists, health professionals, scientists, researchers, policy makers and health workers to present their latest research ideas, development and applications in all areas of public health (maternal & child health) and Nutrition.

The COE aims to disseminate Sukarya's 20+ year experience of helping millions of women and children on issues of entrepreneurship, women's health, reproductive justice, sexual violence, equality, and education. In pursuance of this aim, Sukarya USA has started a fundraising campaign to raise $185,000 dollars. You can visit the COE website at www.sukaryacoe.org.

Yes, the time has changed. And it's all about women. They have continued to speak up, run for office and take their seats at decision-making tables. From the historic number of women running for office this year to #MeToo and #TimesUp, there is huge momentum building, all centered around women.

Adds 4 trademarks - Nutrafer™, Dietofer™ and IDAXTM in Iron Deficiency and TolPlus™ in Gluten Intolerance

After the devastating loss of their cat to severe anemia, a team set out to develop a safe treatment for anemia in pets.

Bio3 Research S.r.l., Milan - Italy, has been granted by the USPTO a patent which claims the use of oral L-cysteine (Biocysan®) in patients with impaired renal functions who are exposed to severe anemia and to oxidative stress.

The Cooley's Anemia Foundation, dedicated to battling the blood disorder thalassemia, will benefit from special walk-a-thon.